How cellular metabolism drives inflammatory microglia in brain aging

As we age, microglial cells in the brain undergo a metabolic reprogramming that transforms them from protective immune sentinels into drivers of chronic inflammation, accelerating neurodegeneration and vulnerability to age-related diseases. Researchers have identified that specific metabolic pathways—those governing phagocytosis, cytokine production, and oxidative stress response—are critical determinants of how these resident CNS immune cells behave during healthy aging and disease progression, with notable sex-specific differences observed in Alzheimer's and Parkinson's pathology. The metabolic shift appears central to the low-grade chronic inflammation characteristic of the aging brain, creating a therapeutic opportunity previously overlooked: restoring microglial metabolic homeostasis could interrupt the inflammatory cascade at its source rather than treating downstream consequences. For the longevity-focused clinician and biohacker, this research signals that next-generation neuroprotective interventions will likely target the metabolic regulators that control microglial states, offering a more precise approach to preserving cognitive function across the lifespan.